As the paper notes, shortages have arisen because drug makers failed to build enough production capacity, maintain equipment or ward off contamination in aging plants. An FDA crackdown on shoddy quality unintentionally worsened the shortages because some companies responded by shutting down plants or scaling back production during renovations.

The Number of Drug Shortages — And Patient Frustration — Keeps Growing